JACQUELINE ARANT: Open Payments
NPI 1518470509 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$903 in 39 payments from 7 companies in 2025. Trend: 2023 $147 · 2024 $192 · 2025 $903
Food & beverage: $903
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 14 | $355 |
| ABBVIE INC. | 10 | $221 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $82 |
| Otsuka America Pharmaceutical, Inc. | 3 | $75 |
| Lundbeck LLC | 3 | $69 |
| Vanda Pharmaceuticals Inc. | 3 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
Products named: Auvelity, VRAYLAR, REXULTI, CAPLYTA, FANAPT, TRINTELLIX, BOTOX.
Industry payments across IL — which companies pay providers there.
